In deliveryUnited Kingdom
Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult
- Published
- Published 8 December 2025
Overview
Medicines Discovery Catapult (MDC) intends to award a contract for the purchase of a Xenium single-cell spatial transcriptomics/proteomics instrument to 10X Genomics. The purchase of the equipment will be at a value of £220,000, with the possibility for four twelve month extension of warranty periods.
Key details
- Country
- United Kingdom
- Status
- In delivery
- Procedure
- Direct
- Published
- 8 December 2025
Award outcome
- Awarded value
- £344,000
- Award date
- 8 December 2025
- Contract period
- 18 December 2025 → 17 December 2026
- 10x Genomics Inc
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
5 January 2026
View notice ↗Contract
8 December 2025
View notice ↗Contract
8 December 2025
View notice ↗
Contracting authority
MEDICINES DISCOVERY CATAPULT LIMITED
BuyerMacclesfield, United Kingdom
GB-COH: 09928547
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.